drugset / Trial / NCT05321758

Fecal Microbiota Transplantation as the First-line Treatment in Active Pediatric Crohn's Disease

NCT05321758

Recruiting 50 enrolled Tongji Hospital
Non-randomizedParallel-groupOpen-labelTreatment

Summary

To explore the safety and effectiveness of repeated and multiple fecal microbiota transplantations (FMTs) plus partial enteral nutrition (PEN) as a first-line treatment for active Crohn's disease (CD) in children.

Timeline

Start
2020-03-22
Primary completion
2027-06-30
Completion
2027-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azathioprine Small molecule
Comparator Thalidomide Other / unclassified

Indications